Call for combination therapy in high-risk cardiovascular patients

LDL-C test

This content has been produced by ADG in association with Amgen.

There is still a large gap between guideline-recommended LDL-C target levels in high-risk patients and what is achieved in real world practice, warn leading cardiologists in a new viewpoint article.1